news
Early Diagnosis and Timely Treatment: expert-defined priorities in the management of Fabry Disease presented at the “Orphan Diseases” сongress
Participants discussed contemporary approaches to the diagnosis and therapy of the Fabry disease in the symposium "From the Patient’s Voice to an Accurate Diagnosis: Assembling the Puzzle of Fabry Disease," held during the VIII All Russian Scientific and Practical Congress with International Participation "Orphan Diseases,"
Petrovax Pharm to launch exports of medicinal products to South Africa
Petrovax Pharm presents immuno-oncology innovation at opening of new Moscow City Oncology Hospital No. 62 Complex in Skolkovo
A Study Evaluating Longidaza® Published in Urologia Journal: Combination Treatment Reduced the Risk of Chronic Prostatitis Recurrence Nearly Fourfold
Russia and China expand partnership in pharmaceuticals and biotechnology
A Russian compound becomes the first in the world to demonstrate a significant improvement of exercise tolerance among patients with post-COVID lung injury in a multicenter randomized controlled trial
Petrovax Pharm joins industry discussion on expanding access to innovative therapy at Forum in Uzbekistan
Measures to accelerate market access for innovative medicines discussed at SPIEF
RANEPA and Petrovax Pharm to Assess the Pharmaceutical Industry’s Contribution to Russia’s Economic and Scientific Development
